E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers T > Headlines for Tenders 2009 > News item
Published on 6/17/2009 in the Prospect News Convertibles Daily.

Pharming Group exchanges €9 million of its convertible debt for shares

By Devika Patel

Knoxville, Tenn., June 17 - Pharming Group NV announced it has reached an agreement with several bondholders to cancel €9 million of its convertible bonds.

The investors agreed to exchange their securities for 8 million ordinary shares.

The total amount of the company's convertible debts remaining outstanding is now €35.8 million.

Pharming Group is a biotechnology company based in Leiden, the Netherlands.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.